Generic Drugs Forum (GDF) 2025 - Day 1

Generic Drugs Forum (GDF) 2025 - Day 2

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms - Implementing the Final Guidance

CDER BIMO: Electronic Submission Requirements for New Drug and Biologic Licensing Applications

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

FDA Expert Panel on Testosterone Replacement Therapy for Men

Medical Device Quality Management System Regulation Risk Management

FDA Direct: FDA Awards Six National Priority Vouchers

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

FDA Direct: Catching Up on Agency Reforms

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Medical Device Quality Management System Regulation Design and Development

How does the FDA approve new drugs?

10 More Facts about What FDA Does and Does Not Approve | #FDAFacts 11-20

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Public Meeting: Reauthorization of the Biosimilar User Fee Act

GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Establishment Registration– DRLS Workshop 2020